Metastatic bone disease: Role of transcription factors and future targets

被引:76
作者
Pratap, Jitesh [1 ]
Lian, Jane B. [2 ,3 ]
Stein, Gary S. [2 ,3 ]
机构
[1] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA
[2] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA
[3] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA
关键词
Runx/AML/Cbfa1; factors; Runx2; MicroRNA; Breast and prostate tumors in bone; Osteolytic disease; Subnuclear targeting; Smads; PROSTATE-CANCER CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA SUPERFAMILY; GROWTH-FACTOR-BETA; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; MORPHOGENETIC PROTEIN-7; RUNX2; EXPRESSION; TUMOR-GROWTH; BREAST;
D O I
10.1016/j.bone.2010.05.035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Progression of cancer from the earliest event of cell transformation through stages of tumor growth and metastasis at a distal site involves many complex biological processes. Underlying the numerous responses of cancer cells to the tumor microenvironment which support their survival, migration and metastasis are transcription factors that regulate the expression of genes reflecting properties of the tumor cell. A number of transcription factors have been identified that play key roles in promoting oncogenesis, tumor growth, metastasis and tissue destruction. Relevant to solid tumors and leukemias, tissue-specific transcription factors that are deregulated resulting from mutations, being silenced or aberrantly expressed, have been well characterized. These are the master transcription factors of the Runx family of genes, the focus of this review, with emphasis placed on Runx2 that is abnormally expressed at very high levels in cancer cell lines that are metastatic to bone. Recent evidence has identified a correlation of Runx2 levels in advanced stages of prostate and breast cancer and demonstrated that effective depletion of Runx2 by RNA interference inhibits migration and invasive properties of the cells prevents metastatic bone disease. This striking effect is consistent with the broad spectrum of Runx2 properties in activating many genes in tumor cells that have already been established as indicators of bone metastasis in poor prognosis. Potential strategies to translate these findings for therapeutic applications are discussed. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:30 / 36
页数:7
相关论文
共 96 条
  • [1] Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions
    Akech, J.
    Wixted, J. J.
    Bedard, K.
    van der Deen, M.
    Hussain, S.
    Guise, T. A.
    van Wijnen, A. J.
    Stein, J. L.
    Languino, L. R.
    Altieri, D. C.
    Pratap, J.
    Keller, E.
    Stein, G. S.
    Lian, J. B.
    [J]. ONCOGENE, 2010, 29 (06) : 811 - 821
  • [2] BMP7 influences proliferation, migration, and invasion of breast cancer cells
    Alarmo, Emma-Leena
    Parssinen, Jenita
    Ketolainen, Johanna M.
    Savinainen, Kimmo
    Karhu, Ritva
    Kallioniemi, Anne
    [J]. CANCER LETTERS, 2009, 275 (01) : 35 - 43
  • [3] Phenotypic transcription factors epigenetically mediate cell growth control
    Ali, Syed A.
    Zaidi, Sayyed K.
    Dacwag, Caroline S.
    Salma, Nunciada
    Young, Daniel W.
    Shakoori, Abdul R.
    Montecino, Martin A.
    Lian, Jane B.
    van Wijnen, Andre J.
    Imbalzano, Anthony N.
    Stein, Gary S.
    Stein, Janet L.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (18) : 6632 - 6637
  • [4] Opinion - Survivin, cancer networks and pathway-directed drug discovery
    Altieri, Dario C.
    [J]. NATURE REVIEWS CANCER, 2008, 8 (01) : 61 - 70
  • [5] ARAUJO J, 2010, CANC TREAT REV
  • [6] The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes
    Bakshi, Rachit
    Zaidi, Sayyed K.
    Pande, Sandhya
    Hassan, Mohammad Q.
    Young, Daniel W.
    Montecino, Martin
    Lian, Jane B.
    van Wijnen, Andre J.
    Stein, Janet L.
    Stein, Gary S.
    [J]. JOURNAL OF CELL SCIENCE, 2008, 121 (23) : 3981 - 3990
  • [7] Repression of Runx2 by Androgen Receptor (AR) in Osteoblasts and Prostate Cancer Cells: AR Binds Runx2 and Abrogates Its Recruitment to DNA
    Baniwal, Sanjeev K.
    Khalid, Omar
    Sir, Donna
    Buchanan, Grant
    Coetzee, Gerhard A.
    Frenkel, Baruch
    [J]. MOLECULAR ENDOCRINOLOGY, 2009, 23 (08) : 1203 - 1214
  • [8] Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease
    Barnes, GL
    Hebert, KE
    Kamal, M
    Javed, A
    Einhorn, TA
    Lian, JB
    Stein, GS
    Gerstenfeld, LC
    [J]. CANCER RESEARCH, 2004, 64 (13) : 4506 - 4513
  • [9] Barnes GL, 2003, CANCER RES, V63, P2631
  • [10] Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
    Bellahcene, Akeila
    Castronovo, Vincent
    Ogbureke, Kalu U. E.
    Fisher, Larry W.
    Fedarko, Neal S.
    [J]. NATURE REVIEWS CANCER, 2008, 8 (03) : 212 - 226